Clinical Trial Update: A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of RO5185426 in previously treated melanoma patients with brain metastases has completed and posted results. The trial was sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• RO5185426

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2015-08-07